Antiseizure medication and perceived "fair" cost allocation: A factorial survey among neurologists, persons with epilepsy, their relatives, and a control group.

Jenny StritzelbergerKatrin WaltherDavid OlmesStefanie GollwitzerWolfgang GrafTamara M Welte Johannes D Lang Caroline ReindlStefan SchwabPeter KriwyHajo M Hamer

Published in: Epilepsia (2022)

ASM effectiveness appears to justify higher costs. However, the control group attributed less money to older PWEs and physicians allocated fewer drug costs to unemployed PWEs.

Keyphrases

physical activity
primary care
randomized controlled trial
systematic review
adverse drug
depressive symptoms
healthcare
mental health
social support
cross sectional
middle aged
emergency department
drug induced